Report Detail
Global Pulmonary Drug Delivery Devices Market Insights and Forecast to 2026
- RnM4135838 |
- 14 August, 2020 |
- Global |
- 147 Pages |
- QYResearch |
- Medical Devices & Consumables
Pulmonary Drug Delivery Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pulmonary Drug Delivery Devices market is segmented into
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Segment by Application, the Pulmonary Drug Delivery Devices market is segmented into
Asthma
COPD
Cystic Fibrosis
Other
Regional and Country-level Analysis
The Pulmonary Drug Delivery Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pulmonary Drug Delivery Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Pulmonary Drug Delivery Devices Market Share Analysis
Pulmonary Drug Delivery Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Pulmonary Drug Delivery Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Pulmonary Drug Delivery Devices business, the date to enter into the Pulmonary Drug Delivery Devices market, Pulmonary Drug Delivery Devices product introduction, recent developments, etc.
The major vendors covered:
Boehringer Ingelheim GmbH
Novartis AG
GlaxoSmithKline
AstraZeneca
Teva Pharmaceutical Industries
Merck
MannKind
Bristol-Myers Squibb
Mylan N.V
Omron Corp
F. Hoffmann-La Roche
3M Healthcare
Sunovion Pharmaceuticals
Koninklijke Philips N.V
Gerresheimer AG
Bespak
AptarGroup
SHL Group
Nypro Healthcare
Hovione
Chiesi Farmaceutici S.P.A
1 Study Coverage
- 1.1 Pulmonary Drug Delivery Devices Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Pulmonary Drug Delivery Devices Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Pulmonary Drug Delivery Devices Market Size Growth Rate by Type
- 1.4.2 Dry Powder Inhaler
- 1.4.3 Metered Dose Inhaler
- 1.4.4 Nebulizer
- 1.5 Market by Application
- 1.5.1 Global Pulmonary Drug Delivery Devices Market Size Growth Rate by Application
- 1.5.2 Asthma
- 1.5.3 COPD
- 1.5.4 Cystic Fibrosis
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Pulmonary Drug Delivery Devices Market Size, Estimates and Forecasts
- 2.1.1 Global Pulmonary Drug Delivery Devices Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Pulmonary Drug Delivery Devices Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Pulmonary Drug Delivery Devices Production Estimates and Forecasts 2015-2026
- 2.2 Global Pulmonary Drug Delivery Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Pulmonary Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Pulmonary Drug Delivery Devices Manufacturers Geographical Distribution
- 2.4 Key Trends for Pulmonary Drug Delivery Devices Markets & Products
- 2.5 Primary Interviews with Key Pulmonary Drug Delivery Devices Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Pulmonary Drug Delivery Devices Manufacturers by Production Capacity
- 3.1.1 Global Top Pulmonary Drug Delivery Devices Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Pulmonary Drug Delivery Devices Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Pulmonary Drug Delivery Devices Manufacturers Market Share by Production
- 3.2 Global Top Pulmonary Drug Delivery Devices Manufacturers by Revenue
- 3.2.1 Global Top Pulmonary Drug Delivery Devices Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Pulmonary Drug Delivery Devices Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Pulmonary Drug Delivery Devices Revenue in 2019
- 3.3 Global Pulmonary Drug Delivery Devices Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Pulmonary Drug Delivery Devices Production by Regions
- 4.1 Global Pulmonary Drug Delivery Devices Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Pulmonary Drug Delivery Devices Regions by Production (2015-2020)
- 4.1.2 Global Top Pulmonary Drug Delivery Devices Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Pulmonary Drug Delivery Devices Production (2015-2020)
- 4.2.2 North America Pulmonary Drug Delivery Devices Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Pulmonary Drug Delivery Devices Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Pulmonary Drug Delivery Devices Production (2015-2020)
- 4.3.2 Europe Pulmonary Drug Delivery Devices Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Pulmonary Drug Delivery Devices Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Pulmonary Drug Delivery Devices Production (2015-2020)
- 4.4.2 China Pulmonary Drug Delivery Devices Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Pulmonary Drug Delivery Devices Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Pulmonary Drug Delivery Devices Production (2015-2020)
- 4.5.2 Japan Pulmonary Drug Delivery Devices Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Pulmonary Drug Delivery Devices Import & Export (2015-2020)
5 Pulmonary Drug Delivery Devices Consumption by Region
- 5.1 Global Top Pulmonary Drug Delivery Devices Regions by Consumption
- 5.1.1 Global Top Pulmonary Drug Delivery Devices Regions by Consumption (2015-2020)
- 5.1.2 Global Top Pulmonary Drug Delivery Devices Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Pulmonary Drug Delivery Devices Consumption by Application
- 5.2.2 North America Pulmonary Drug Delivery Devices Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Pulmonary Drug Delivery Devices Consumption by Application
- 5.3.2 Europe Pulmonary Drug Delivery Devices Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Pulmonary Drug Delivery Devices Consumption by Application
- 5.4.2 Asia Pacific Pulmonary Drug Delivery Devices Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Pulmonary Drug Delivery Devices Consumption by Application
- 5.5.2 Central & South America Pulmonary Drug Delivery Devices Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Pulmonary Drug Delivery Devices Consumption by Application
- 5.6.2 Middle East and Africa Pulmonary Drug Delivery Devices Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Pulmonary Drug Delivery Devices Market Size by Type (2015-2020)
- 6.1.1 Global Pulmonary Drug Delivery Devices Production by Type (2015-2020)
- 6.1.2 Global Pulmonary Drug Delivery Devices Revenue by Type (2015-2020)
- 6.1.3 Pulmonary Drug Delivery Devices Price by Type (2015-2020)
- 6.2 Global Pulmonary Drug Delivery Devices Market Forecast by Type (2021-2026)
- 6.2.1 Global Pulmonary Drug Delivery Devices Production Forecast by Type (2021-2026)
- 6.2.2 Global Pulmonary Drug Delivery Devices Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Pulmonary Drug Delivery Devices Price Forecast by Type (2021-2026)
- 6.3 Global Pulmonary Drug Delivery Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Pulmonary Drug Delivery Devices Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Pulmonary Drug Delivery Devices Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 Boehringer Ingelheim GmbH
- 8.1.1 Boehringer Ingelheim GmbH Corporation Information
- 8.1.2 Boehringer Ingelheim GmbH Overview
- 8.1.3 Boehringer Ingelheim GmbH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 Boehringer Ingelheim GmbH Product Description
- 8.1.5 Boehringer Ingelheim GmbH Related Developments
- 8.2 Novartis AG
- 8.2.1 Novartis AG Corporation Information
- 8.2.2 Novartis AG Overview
- 8.2.3 Novartis AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 Novartis AG Product Description
- 8.2.5 Novartis AG Related Developments
- 8.3 GlaxoSmithKline
- 8.3.1 GlaxoSmithKline Corporation Information
- 8.3.2 GlaxoSmithKline Overview
- 8.3.3 GlaxoSmithKline Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 GlaxoSmithKline Product Description
- 8.3.5 GlaxoSmithKline Related Developments
- 8.4 AstraZeneca
- 8.4.1 AstraZeneca Corporation Information
- 8.4.2 AstraZeneca Overview
- 8.4.3 AstraZeneca Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 AstraZeneca Product Description
- 8.4.5 AstraZeneca Related Developments
- 8.5 Teva Pharmaceutical Industries
- 8.5.1 Teva Pharmaceutical Industries Corporation Information
- 8.5.2 Teva Pharmaceutical Industries Overview
- 8.5.3 Teva Pharmaceutical Industries Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 Teva Pharmaceutical Industries Product Description
- 8.5.5 Teva Pharmaceutical Industries Related Developments
- 8.6 Merck
- 8.6.1 Merck Corporation Information
- 8.6.2 Merck Overview
- 8.6.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 Merck Product Description
- 8.6.5 Merck Related Developments
- 8.7 MannKind
- 8.7.1 MannKind Corporation Information
- 8.7.2 MannKind Overview
- 8.7.3 MannKind Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 MannKind Product Description
- 8.7.5 MannKind Related Developments
- 8.8 Bristol-Myers Squibb
- 8.8.1 Bristol-Myers Squibb Corporation Information
- 8.8.2 Bristol-Myers Squibb Overview
- 8.8.3 Bristol-Myers Squibb Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 Bristol-Myers Squibb Product Description
- 8.8.5 Bristol-Myers Squibb Related Developments
- 8.9 Mylan N.V
- 8.9.1 Mylan N.V Corporation Information
- 8.9.2 Mylan N.V Overview
- 8.9.3 Mylan N.V Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.9.4 Mylan N.V Product Description
- 8.9.5 Mylan N.V Related Developments
- 8.10 Omron Corp
- 8.10.1 Omron Corp Corporation Information
- 8.10.2 Omron Corp Overview
- 8.10.3 Omron Corp Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.10.4 Omron Corp Product Description
- 8.10.5 Omron Corp Related Developments
- 8.11 F. Hoffmann-La Roche
- 8.11.1 F. Hoffmann-La Roche Corporation Information
- 8.11.2 F. Hoffmann-La Roche Overview
- 8.11.3 F. Hoffmann-La Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.11.4 F. Hoffmann-La Roche Product Description
- 8.11.5 F. Hoffmann-La Roche Related Developments
- 8.12 3M Healthcare
- 8.12.1 3M Healthcare Corporation Information
- 8.12.2 3M Healthcare Overview
- 8.12.3 3M Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.12.4 3M Healthcare Product Description
- 8.12.5 3M Healthcare Related Developments
- 8.13 Sunovion Pharmaceuticals
- 8.13.1 Sunovion Pharmaceuticals Corporation Information
- 8.13.2 Sunovion Pharmaceuticals Overview
- 8.13.3 Sunovion Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.13.4 Sunovion Pharmaceuticals Product Description
- 8.13.5 Sunovion Pharmaceuticals Related Developments
- 8.14 Koninklijke Philips N.V
- 8.14.1 Koninklijke Philips N.V Corporation Information
- 8.14.2 Koninklijke Philips N.V Overview
- 8.14.3 Koninklijke Philips N.V Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.14.4 Koninklijke Philips N.V Product Description
- 8.14.5 Koninklijke Philips N.V Related Developments
- 8.15 Gerresheimer AG
- 8.15.1 Gerresheimer AG Corporation Information
- 8.15.2 Gerresheimer AG Overview
- 8.15.3 Gerresheimer AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.15.4 Gerresheimer AG Product Description
- 8.15.5 Gerresheimer AG Related Developments
- 8.16 Bespak
- 8.16.1 Bespak Corporation Information
- 8.16.2 Bespak Overview
- 8.16.3 Bespak Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.16.4 Bespak Product Description
- 8.16.5 Bespak Related Developments
- 8.17 AptarGroup
- 8.17.1 AptarGroup Corporation Information
- 8.17.2 AptarGroup Overview
- 8.17.3 AptarGroup Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.17.4 AptarGroup Product Description
- 8.17.5 AptarGroup Related Developments
- 8.18 SHL Group
- 8.18.1 SHL Group Corporation Information
- 8.18.2 SHL Group Overview
- 8.18.3 SHL Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.18.4 SHL Group Product Description
- 8.18.5 SHL Group Related Developments
- 8.19 Nypro Healthcare
- 8.19.1 Nypro Healthcare Corporation Information
- 8.19.2 Nypro Healthcare Overview
- 8.19.3 Nypro Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.19.4 Nypro Healthcare Product Description
- 8.19.5 Nypro Healthcare Related Developments
- 8.20 Hovione
- 8.20.1 Hovione Corporation Information
- 8.20.2 Hovione Overview
- 8.20.3 Hovione Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.20.4 Hovione Product Description
- 8.20.5 Hovione Related Developments
- 8.21 Chiesi Farmaceutici S.P.A
- 8.21.1 Chiesi Farmaceutici S.P.A Corporation Information
- 8.21.2 Chiesi Farmaceutici S.P.A Overview
- 8.21.3 Chiesi Farmaceutici S.P.A Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.21.4 Chiesi Farmaceutici S.P.A Product Description
- 8.21.5 Chiesi Farmaceutici S.P.A Related Developments
9 Pulmonary Drug Delivery Devices Production Forecast by Regions
- 9.1 Global Top Pulmonary Drug Delivery Devices Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Pulmonary Drug Delivery Devices Regions Forecast by Production (2021-2026)
- 9.3 Key Pulmonary Drug Delivery Devices Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Pulmonary Drug Delivery Devices Consumption Forecast by Region
- 10.1 Global Pulmonary Drug Delivery Devices Consumption Forecast by Region (2021-2026)
- 10.2 North America Pulmonary Drug Delivery Devices Consumption Forecast by Region (2021-2026)
- 10.3 Europe Pulmonary Drug Delivery Devices Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Pulmonary Drug Delivery Devices Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Pulmonary Drug Delivery Devices Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Pulmonary Drug Delivery Devices Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Pulmonary Drug Delivery Devices Sales Channels
- 11.2.2 Pulmonary Drug Delivery Devices Distributors
- 11.3 Pulmonary Drug Delivery Devices Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Pulmonary Drug Delivery Devices Industry
- 12.2 Market Trends
- 12.3 Market Opportunities and Drivers
- 12.4 Market Challenges
- 12.5 Pulmonary Drug Delivery Devices Market Risks/Restraints
- 12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Pulmonary Drug Delivery Devices Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Pulmonary Drug Delivery Devices. Industry analysis & Market Report on Pulmonary Drug Delivery Devices is a syndicated market report, published as Global Pulmonary Drug Delivery Devices Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Pulmonary Drug Delivery Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
